Tirzepatide liver‑failure alert

- Clinicians shared a case of a young patient who developed acute liver failure after using Paraguayan‑sourced tirzepatide, raising safety concerns about unsupervised drug access and online purchases. - The social post warned of a severe toxicity event tied to tirzepatide use sourced abroad, with account holders urging clinicians to be alert for hepatic injury patterns. - Experts on social channels urged caution, reminding that prescription drugs bought overseas can carry dosing and impurity risks and require physician oversight. (x.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.